glp 1 benefits and risks GLP-1 drugs improve liver heart health GLP-1 Agonists For Obesity In

Once you start, can you ever stop

A 2022 study published in Diabetes, Obesity and Metabolism found that adults over 50 achieved clinically significant weight loss on semaglutide, with cardiovascular and metabolic risk reductions comparable to younger cohorts, though the authors noted the importance of individualized monitoring protocols for older patients given the higher baseline prevalence of comorbidities

Your provider will adjust every four weeks until you reach your optimal dose, semaglutide around 2.4 mg, tirzepatide around 5, 10, or 15 mg

Planning ahead makes it less likely that you'll experience gaps in use, which can disrupt results

By lowering blood sugar, the GLP-1 drugs can help protect the kidneys from this detrimental effect, which may delay or prevent kidney disease and kidney failure